Literature DB >> 31791659

APOE ε4-specific associations of VEGF gene family expression with cognitive aging and Alzheimer's disease.

Annah M Moore1, Emily Mahoney2, Logan Dumitrescu2, Philip L De Jager3, Mary Ellen I Koran4, Vladislav A Petyuk5, Renã As Robinson6, Douglas M Ruderfer7, Nancy J Cox7, Julie A Schneider8, David A Bennett8, Angela L Jefferson9, Timothy J Hohman10.   

Abstract

Literature suggests vascular endothelial growth factor A (VEGFA) is protective among those at highest risk for Alzheimer's disease (AD). Apolipoprotein E (APOE) ε4 allele carriers represent a highly susceptible population for cognitive decline, and VEGF may confer distinct protection among APOE-ε4 carriers. We evaluated interactions between cortical expression of 10 VEGF gene family members and APOE-ε4 genotype to clarify which VEGF genes modify the association between APOE-ε4 and cognitive decline. Data were obtained from the Religious Orders Study and Rush Memory and Aging Project (N = 531). Linear regression assessed interactions on global cognition. VEGF genes NRP1 and VEGFA interacted with APOE-ε4 on cognitive performance (p.fdr < 0.05). Higher NRP1 expression correlated with worse outcomes among ε4 carriers but better outcomes among ε4 noncarriers, suggesting NRP1 modifies the risk for poor cognitive scores based on APOE-ε4 status. NRP1 regulates angiogenesis, and literature suggests vessels in APOE-ε4 brains are more prone to leaking, perhaps placing young vessels at risk for ischemia. Results suggest that future therapeutics targeting brain angiogenesis should also consider ε4 allele status.
Copyright © 2019 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  APOE-ε4; Aging; Cognition; Gene expression; Vascular endothelial growth factor (VEGF)

Mesh:

Substances:

Year:  2019        PMID: 31791659      PMCID: PMC7064375          DOI: 10.1016/j.neurobiolaging.2019.10.021

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  70 in total

1.  Increased intrathecal levels of the angiogenic factors VEGF and TGF-beta in Alzheimer's disease and vascular dementia.

Authors:  Elisabeth Tarkowski; Razao Issa; Magnus Sjögren; Anders Wallin; Kaj Blennow; Andrej Tarkowski; Pat Kumar
Journal:  Neurobiol Aging       Date:  2002 Mar-Apr       Impact factor: 4.673

2.  Cerebrovascular disease pathology and parkinsonian signs in old age.

Authors:  Aron S Buchman; Sue E Leurgans; Sukriti Nag; David A Bennett; Julie A Schneider
Journal:  Stroke       Date:  2011-09-01       Impact factor: 7.914

3.  Role of vascular endothelial growth factor receptor-3/Flt-4 in early-stage cervical cancer.

Authors:  Shiqian Zhang; Hao Yu; Linlin Zhang
Journal:  Oncol Lett       Date:  2010-05-01       Impact factor: 2.967

Review 4.  Vascular endothelial growth factor biology for regenerative angiogenesis.

Authors:  Andrea Uccelli; Thomas Wolff; Paolo Valente; Nunzia Di Maggio; Matteo Pellegrino; Lorenz Gürke; Andrea Banfi; Roberto Gianni-Barrera
Journal:  Swiss Med Wkly       Date:  2019-01-27       Impact factor: 2.193

Review 5.  The role of apolipoprotein E in Alzheimer's disease.

Authors:  Jungsu Kim; Jacob M Basak; David M Holtzman
Journal:  Neuron       Date:  2009-08-13       Impact factor: 17.173

Review 6.  Religious Orders Study and Rush Memory and Aging Project.

Authors:  David A Bennett; Aron S Buchman; Patricia A Boyle; Lisa L Barnes; Robert S Wilson; Julie A Schneider
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

7.  VEGF-A165b is an endogenous neuroprotective splice isoform of vascular endothelial growth factor A in vivo and in vitro.

Authors:  Nicholas Beazley-Long; Jing Hua; Thomas Jehle; Richard P Hulse; Rick Dersch; Christina Lehrling; Heather Bevan; Yan Qiu; Wolf A Lagrèze; David Wynick; Amanda J Churchill; Patrick Kehoe; Steven J Harper; David O Bates; Lucy F Donaldson
Journal:  Am J Pathol       Date:  2013-07-06       Impact factor: 4.307

8.  VEGF significantly restores impaired memory behavior in Alzheimer's mice by improvement of vascular survival.

Authors:  Piotr Religa; Renhai Cao; Dorota Religa; Yuan Xue; Nenad Bogdanovic; David Westaway; Hugo H Marti; Bengt Winblad; Yihai Cao
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

9.  24-hour rhythms of DNA methylation and their relation with rhythms of RNA expression in the human dorsolateral prefrontal cortex.

Authors:  Andrew S P Lim; Gyan P Srivastava; Lei Yu; Lori B Chibnik; Jishu Xu; Aron S Buchman; Julie A Schneider; Amanda J Myers; David A Bennett; Philip L De Jager
Journal:  PLoS Genet       Date:  2014-11-06       Impact factor: 5.917

Review 10.  Inflammation as a central mechanism in Alzheimer's disease.

Authors:  Jefferson W Kinney; Shane M Bemiller; Andrew S Murtishaw; Amanda M Leisgang; Arnold M Salazar; Bruce T Lamb
Journal:  Alzheimers Dement (N Y)       Date:  2018-09-06
View more
  9 in total

1.  Proposed minimal essential co-expression and physical interaction networks involved in the development of cognition impairment in human mid and late life.

Authors:  Zahra Salehi; Masoud Arabfard; Omid Sadatpour; Mina Ohadi
Journal:  Neurol Sci       Date:  2020-07-16       Impact factor: 3.307

2.  Investigating the Effect of Inosine on Brain Purinergic Receptors and Neurotrophic and Neuroinflammatory Parameters in an Experimental Model of Alzheimer's Disease.

Authors:  Fernanda Cardoso Teixeira; Mayara Sandrielly Pereira Soares; Eduardo Bierhaus Blödorn; William Borges Domingues; Karine Paula Reichert; Adriana Maria Zago; Fabiano Barbosa Carvalho; Jessie Martins Gutierres; Relber Aguiar Gonçales; Marilda da Cruz Fernandes; Vinicius Farias Campos; Maria Rosa Chitolina; Francieli Moro Stefanello; Roselia Maria Spanevello
Journal:  Mol Neurobiol       Date:  2021-11-18       Impact factor: 5.590

Review 3.  Autophagy Balances Neuroinflammation in Alzheimer's Disease.

Authors:  Xuehua Cheng; Yong Wei; Zijun Qian; Li Han
Journal:  Cell Mol Neurobiol       Date:  2022-08-12       Impact factor: 4.231

4.  Phosphorylated Tau 181 Serum Levels Predict Alzheimer's Disease in the Preclinical Stage.

Authors:  Wei Qin; Fangyu Li; Longfei Jia; Qi Wang; Ying Li; Yiping Wei; Yan Li; Hongmei Jin; Jianping Jia
Journal:  Front Aging Neurosci       Date:  2022-06-13       Impact factor: 5.702

Review 5.  From Brain to Heart: Possible Role of Amyloid-β in Ischemic Heart Disease and Ischemia-Reperfusion Injury.

Authors:  Giulia Gagno; Federico Ferro; Alessandra Lucia Fluca; Milijana Janjusevic; Maddalena Rossi; Gianfranco Sinagra; Antonio Paolo Beltrami; Rita Moretti; Aneta Aleksova
Journal:  Int J Mol Sci       Date:  2020-12-17       Impact factor: 5.923

6.  A Tau Pathogenesis-Based Network Pharmacology Approach for Exploring the Protections of Chuanxiong Rhizoma in Alzheimer's Disease.

Authors:  Peng Zeng; Hong-Fei Su; Chao-Yuan Ye; Shuo-Wen Qiu; Anbing Shi; Jian-Zhi Wang; Xin-Wen Zhou; Qing Tian
Journal:  Front Pharmacol       Date:  2022-04-21       Impact factor: 5.988

7.  VEGF-A-related genetic variants protect against Alzheimer's disease.

Authors:  Alexandros M Petrelis; Maria G Stathopoulou; Maria Kafyra; Helena Murray; Christine Masson; John Lamont; Peter Fitzgerald; George Dedoussis; Frances T Yen; Sophie Visvikis-Siest
Journal:  Aging (Albany NY)       Date:  2022-03-28       Impact factor: 5.682

Review 8.  Signalling, Metabolic Pathways and Iron Homeostasis in Endothelial Cells in Health, Atherosclerosis and Alzheimer's Disease.

Authors:  Emy Bosseboeuf; Claudio Raimondi
Journal:  Cells       Date:  2020-09-08       Impact factor: 6.600

9.  VEGF signalling causes stalls in brain capillaries and reduces cerebral blood flow in Alzheimer's mice.

Authors:  Muhammad Ali; Kaja Falkenhain; Brendah N Njiru; Muhammad Murtaza-Ali; Nancy E Ruiz-Uribe; Mohammad Haft-Javaherian; Stall Catchers; Nozomi Nishimura; Chris B Schaffer; Oliver Bracko
Journal:  Brain       Date:  2022-05-24       Impact factor: 15.255

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.